CVSA Stock Forecast & Price Target

Covista is expected to continue its positive growth trajectory with potential for increased EPS in the future, driven by new campus launches and strong enrollment numbers. However, risks such as a potential slowdown in new starts and regulatory issues should be monitored closely. The company's strong financials, balanced capital allocation, and partnership with Sallie Mae make it an attractive investment opportunity.

Covista is facing challenges in its Chamberlain segment as it has had difficulty executing its marketing strategy. This has led to a decline in post-licensure enrollment, but recent growth in applications and conversion rates suggest a potential turnaround. However, concerns around DeVry liabilities and general regulatory scrutiny in the for-profit education sector continue to weigh on the stock's performance. In light of these challenges, a potential conservative approach and continued skepticism towards the Chamberlain turnaround may justify a negative outlook on the stock.